Notice: This company has been marked as potentially delisted and may not be actively trading. AVITA MED LTD/S (AVMXY) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cantor maintains Avita stock Overweight with $19 targetFebruary 14, 2025 | msn.comAvita medical director Suzanne Crowe buys $6,390 in stockJanuary 30, 2025 | msn.comBTIG Reaffirms Their Hold Rating on Avita Medical (RCEL)January 13, 2025 | markets.businessinsider.comAvita Medical (RCEL) Gets a Buy from Lake StreetJanuary 9, 2025 | markets.businessinsider.comAvita Medical (RCEL) Receives a Hold from BTIGJanuary 7, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Avita Medical (RCEL)December 24, 2024 | markets.businessinsider.comAvita Medical Says FDA Approved Recell GO MiniDecember 23, 2024 | marketwatch.comAvita Medical Shares Rise 6.4% Following FDA ApprovalDecember 23, 2024 | marketwatch.comWhy Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?December 11, 2024 | msn.comLake Street Remains a Buy on Avita Medical (RCEL)November 9, 2024 | markets.businessinsider.comAvita Medical Reports Strong Q3 Revenue GrowthNovember 8, 2024 | markets.businessinsider.comAvita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth ProspectsNovember 8, 2024 | markets.businessinsider.comAVITA Medical IncOctober 29, 2024 | thestreet.comSpectra Medical Devices Acquires XL Precision TechnologiesSeptember 30, 2024 | tmcnet.comAvita Medical Maintains Buy Rating Amid Strong Quarterly Performance and Positive Growth OutlookAugust 9, 2024 | markets.businessinsider.comCantor Fitzgerald Keeps Their Buy Rating on Avita Medical (RCEL)August 9, 2024 | markets.businessinsider.comAvita Medical is about to announce its earnings — here's what to expectAugust 8, 2024 | markets.businessinsider.comRCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q1 2024May 13, 2024 | msn.comAVITA Medical GAAP EPS of -$0.73 misses by $0.24, revenue of $11.1M misses by $0.07MMay 13, 2024 | msn.comThree nurses receive DAISY Award at Avita Health SystemMay 10, 2024 | msn.comHogy Medical Co LtdApril 23, 2024 | morningstar.comLake Street Keeps Their Buy Rating on Avita Medical (RCEL)April 12, 2024 | markets.businessinsider.comAvita Medical Shares Fall 6.6% on Revised 1Q Outlook, 2024 Revenue ExpectationsApril 11, 2024 | marketwatch.comE-Smart Clinic Goes LIVE! A Lord's Mark Initiative for a Healthier India in Collaboration with Government of IndiaMarch 12, 2024 | msn.comMax Healthcare, Aster DM, KIMS shares tank up to 8% today. Here's whyMarch 1, 2024 | msn.comSisram Medical Ltd.February 17, 2024 | wsj.comAvita Ontario Hospital first stop on statewide Ohio Adversity and Resilience Study tourFebruary 5, 2024 | news.yahoo.comAvita Medical misses Q4,FY 23 prelim revenue estimateJanuary 10, 2024 | msn.comAVITA Medical Inc AVHHLNovember 23, 2023 | morningstar.comAvita Medical Shares Drop After 2023 Commercial Revenue Outlook CutNovember 21, 2023 | marketwatch.comAVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionNovember 21, 2023 | msn.comAVITA Medical Stock (NASDAQ:RCEL), Analyst Ratings, Price Targets, PredictionsNovember 11, 2023 | benzinga.comWhy AVITA Medical, Bellamy's, Evolution, & Volpara shares dropped into the red todayOctober 24, 2023 | fool.com.auWhy Shares of Avita Medical Are Down MondayOctober 2, 2023 | msn.comAnalyst Expectations for AVITA Medical's FutureSeptember 26, 2023 | markets.businessinsider.comQ2 2023 AVITA Medical Inc Earnings CallSeptember 1, 2023 | finance.yahoo.comAVITA's Balancing Act: RECELL System's Promise Amid Market UncertaintiesJuly 20, 2023 | msn.comAvita Medical (ASX:AVH) Price Target Increased by 5.95% to 6.05May 14, 2023 | msn.comAVITA Medical shares are trading lower after the company reported mixed Q1 financial results.May 12, 2023 | benzinga.comPiper Sandler Keeps Their Buy Rating on Avita Medical (RCEL)May 12, 2023 | markets.businessinsider.comHere's what Wall Street expects from AVITA Therapeutics's earnings reportMay 12, 2023 | markets.businessinsider.comBriefs: Avita medication program, Senior Spring Extravaganza, ODNR honorMay 2, 2023 | news.yahoo.comAVITA Medical: At A CrossroadsMarch 19, 2023 | seekingalpha.comQ4 2022 AVITA Medical Inc Earnings CallFebruary 26, 2023 | finance.yahoo.comAvita Medical shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.February 24, 2023 | benzinga.comAvita Care Solutions Names Dr. Christopher Hall First Chief Medical OfficerFebruary 13, 2023 | finance.yahoo.comAvita: Micro-Cap With Big Time Approvals On Near HorizonDecember 17, 2022 | seekingalpha.comMinistry managing medical supplies carefully - DDGSeptember 13, 2022 | msn.comAmrita Hospitals: Making high-quality medical care affordable to allAugust 23, 2022 | yahoo.comImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug DesignationAugust 8, 2022 | yahoo.com Remove Ads Get AVITA MED LTD/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AVMXY and its competitors with MarketBeat's FREE daily newsletter. Email Address AVMXY Media Mentions By Week AVMXY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVMXY News Sentiment▼0.000.79▲Average Medical News Sentiment AVMXY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVMXY Articles This Week▼00▲AVMXY Articles Average Week Remove Ads Get AVITA MED LTD/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AVMXY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Twist Bioscience News Today Recursion Pharmaceuticals News Today Vericel News Today Beam Therapeutics News Today Denali Therapeutics News Today CG Oncology News Today Tarsus Pharmaceuticals News Today Kymera Therapeutics News Today Bavarian Nordic A/S News Today Apogee Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AVMXY) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA MED LTD/S Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA MED LTD/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.